Table 5 Characteristics of strains subjected to real-time PCR quantification
Strain Name | CMI | Â | |
|---|---|---|---|
| Â | Vanco | Teico | Characteristics and origin |
NRS 3 | 4 | 8 | Peritoneal fluid, USA |
NRS 11 | 2 | 2 | Ophthalmologic infection, France |
NRS 12 | 8 | 8 | Ophthalmologic infection, France |
NRS 13 | 4 | 4 | Ophthalmologic infection, France |
NRS 14 | 8 | 8 | Ophthalmologic infection, France |
NRS 17 | 8 | 8 | Bloodstream, USA |
NRS 35 | 2 | 2 | Bloodstream, France |
NRS 56 | 8 | 8 | Wound/skin/soft tissue, Brazil |
NRS 63 | 8 | 8 | Bloodstream, Oman |
NRS 64 | 2 | 2 | Bloodstream, Oman |
Mu50 (NRS1) | 8 | 8 | Wound/skin/soft tissue, Japan [42] |
Mu3 (NRS2) | 0.5 | 2 | Purulent sputum, Japan |
MRGR3 | 1 | 1 | Bloodstream, Switzerland |
14-4 | 8 | 8 | Sub-cutaneous infection with MRGR3, Switzerland [31] |
14-4Rev | 1 | 1 | Sub-cutaneous infection with 14-4, Switzerland [32] |
MW2 | 1 | 1 | Community-acquired Staphylococcus aureus [68] |
COL | 0.5 | 1 | Ancestor strain of MRSA, England [80] |
N315 | 0.5 | 1 | Pharyngeal smear, Japan [42] |